Jacob Sonenshine

Somehow, some way, Nike is crushing it with soccer’s biggest event. Its overall global business is still struggling, though.

These stocks can hold their ground, or even gain, when the market falls. They include Exxon, Chevron, Coca-Cola, Costco, and Duke Energy.

The Roundhill Magnificent Seven ETF is down about 9% from its record high in mid May.

Growth prospects caused the stock to drop but it has now reset and can rise again.

Sales and profit estimates for chip companies have moved higher, valuations have expanded—and volatility is picking up. What to do.

Shares have recovered from multiyear lows. There’s more upside ahead.

Artificial-intelligence stocks are on the rise again, but they come with high volatility. Where to find AI-related stocks that are more stable.

With a potential peace deal in Iran, and oil and yields down from peaks, investors are more confident in the profit outlook for financials.

The VIX has jumped as investors reassess AI spending, interest rates, and economic growth. That could create opportunities in semiconductor, industrial, and homebuilder stocks.

The stock’s performance has left a lot to be desired. Blame AI.

CVS Health, Pfizer, and Dollar General were among the stocks identified for investors looking for non-tech options.

Buyers have plenty of reasons to believe in the sector for the rest of the year and beyond

Gold has dropped from $5,247 per ounce near the end of February to just over $4,500 now.

Despite the week’s declines, the market is more likely to see it as a short correction than a major selloff. Investors aren’t selling everything, but shifting into better opportunities.

Accenture shares have dropped on concerns of AI displacement. That should prove shortsighted.

It’s still up 55% since we introduced it as a pick.

Big Tech has been driving the stock market rally, but these healthcare, financial, and utilities ETFs are starting to look good.

There are reasons to still like the stock, though investors can certainly be forgiven for taking some profits.

Boston Scientific stock has dropped precipitously, causing us to withdraw our Buy rating.

Consumer stocks are suddenly back in favor. Tread carefully with these names.